VIROLOGICAL ANALYSIS OF PATIENTS RECEIVING TELAPREVIR ADMINISTERED Q8H OR Q12H WITH PEGINTERFERON-ALFA-2A OR -ALFA-2B AND RIBAVIRIN IN TREATMENT-NAiVE PATIENTS WITH GENOTYPE 1 HEPATITIS C: STUDY C208

被引:0
|
作者
Marcellin, Patrick [1 ]
Forns, Xavier [2 ]
Goeser, Tobias [3 ]
Ferenci, Peter [4 ]
Nevens, Frederik [5 ]
Carosi, Giampiero [6 ]
Drenth, Joost P. [7 ]
De Backer, Koen [8 ]
van Heeswijk, Rudolf [8 ]
Luo, Donghan [9 ]
Picchio, Gaston [9 ]
Beumont-Mauviel, Maria [8 ]
机构
[1] Hop Beaujon, Liver Unit, Clichy, France
[2] Univ Barcelona, Barcelona, Spain
[3] Klinikum Univ Koln, Cologne, Germany
[4] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria
[5] Univ Hosp Gasthuisberg, Dept Hepatol, B-3000 Leuven, Belgium
[6] Univ Brescia, Clin Infect & Trop Dis, Brescia, Italy
[7] Radboud Univ Nijmegen, Ctr Med, NL-6525 ED Nijmegen, Netherlands
[8] Tibotec BVBA, Mechelen, Belgium
[9] Tibotec Inc, Yardley, PA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
194
引用
收藏
页码:395A / 395A
页数:1
相关论文
共 50 条
  • [41] Genotype dependent pattern of peginterferon alfa-2b/ribavirin treatment failure in hepatitis C virus infected patients with cirrhosis: A single center study of 471 naive patients
    Agbemo, A.
    Rumi, M. G.
    Monico, S.
    Prati, G. M.
    Ronchi, G.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S287 - S287
  • [42] Peginterferon alfa-2b and ribavirin treatment response among Hispanic veterans with chronic hepatitis C genotype 1
    Toro, D
    De Jesus, JJ
    Rodriguez-Perez, F
    Gonzalez, D
    Rivera, I
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S122 - S123
  • [43] Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    Davis, GL
    Wong, JB
    McHutchison, JG
    Manns, MP
    Harvey, J
    Albrecht, J
    HEPATOLOGY, 2003, 38 (03) : 645 - 652
  • [44] Costs of antiviral treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.
    Siebert, U
    Sroczynski, G
    Wasem, J
    Aidelsburger, P
    Rossol, S
    Wong, JB
    HEPATOLOGY, 2002, 36 (04) : 598A - 598A
  • [45] CEPEGINTERFERON-ALFA-2b IN COMBINATION WITH RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C
    Znoyko, O.
    Klimova, E.
    Maximov, S.
    Kizhlo, S.
    Petrochenkova, N.
    Nagimova, F.
    Linkova, Y.
    Ivanov, R.
    Chernovskaya, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S476 - S476
  • [46] Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon Alfa-2B plus ribavirin
    Neumann, Ulf
    Puhl, Gero
    Bahra, Marcus
    Berg, Thomas
    Langrehr, Jan Michael
    Neuhaus, Ruth
    Neuhaus, Peter
    TRANSPLANTATION, 2006, 82 (01) : 43 - 47
  • [47] The role of cholesterol on sustained virological response (SVR) in the treatment of genotype-1 infected hepatitis C (CHC) patients with peginterferon-alfa-2a (PEG) and ribavirin (RBV)
    Mauss, S.
    Zehnter, E.
    Hueppe, D.
    Kaiser, K.
    Boeker, K.
    Lutz, T.
    Heyne, R.
    John, C.
    Moog, G.
    Schober, A.
    Pfaff, R.
    Zipf, A.
    Racky, S.
    Lohmeyer, J.
    Bokemeyer, B.
    Kallinowski, B.
    Witthoeft, T.
    Alshuth, U.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S304 - S304
  • [48] Randomized Trial of Peginterferon Alfa-2b and Ribavirin for 48 or 72 weeks in Patients With Hepatitis C Virus Genotype 1 and Slow Virological Response Reply
    Buti, Maria
    Esteban, Rafael
    HEPATOLOGY, 2010, 52 (04) : 1520 - 1521
  • [49] Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection
    Marcellin, Patrick
    Cooper, Curtis
    Balart, Luis
    Larrey, Dominique
    Box, Terry
    Yoshida, Eric
    Lawitz, Eric
    Buggisch, Peter
    Ferenci, Peter
    Weltman, Martin
    Labriola-Tompkins, Emily
    Le Pogam, Sophie
    Najera, Isabel
    Thomas, Denise
    Hooper, Gregory
    Shulman, Nancy S.
    Zhang, Ying
    Navarro, Mercidita T.
    Lim, Chin Yin
    Brunda, Michael
    Terrault, Norah A.
    Yetzer, Ellen S.
    GASTROENTEROLOGY, 2013, 145 (04) : 790 - +
  • [50] BOCEPREVIR (BOC) COMBINED WITH PEGINTERFERON ALFA-2B/RIBAVIRIN (P/R) FOR TREATMENT-NAiVE PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE (G) 1: SPRINT-2 FINAL RESULTS
    Poordad, Fred
    McCone, Jonathan
    Bacon, Bruce R.
    Bruno, Savino
    Manns, Michael P.
    Sulkowski, Mark S.
    Jacobson, Ira M.
    Reddy, K. Rajender
    Boparai, Navdeep
    Sniukiene, Vilma
    Brass, Clifford A.
    Albrecht, Janice K.
    Bronowicki, Jean-Pierre
    HEPATOLOGY, 2010, 52 (04) : 402A - 403A